Literature DB >> 19109175

MicroRNA-221-222 regulate the cell cycle in mast cells.

Ramon J Mayoral1, Matthew E Pipkin, Mikhail Pachkov, Erik van Nimwegen, Anjana Rao, Silvia Monticelli.   

Abstract

MicroRNAs (miRNAs) constitute a large family of small noncoding RNAs that have emerged as key posttranscriptional regulators in a wide variety of organisms. Because any one miRNA can potentially regulate expression of a distinct set of genes, differential miRNA expression can shape the repertoire of proteins that are actually expressed during development and differentiation or disease. Here, we have used mast cells as a model to investigate the role of miRNAs in differentiated innate immune cells and found that miR-221-222 are significantly up-regulated upon mast cell activation. Using both bioinformatics and experimental approaches, we identified some signaling pathways, transcription factors, and potential cis-regulatory regions that control miR-221-222 transcription. Overexpression of miR-221-222 in a model mast cell line perturbed cell morphology and cell cycle regulation without altering viability. While in stimulated cells miR-221-222 partially counteracted expression of the cell-cycle inhibitor p27(kip1), we found that in the mouse alternative splicing results in two p27(kip1) mRNA isoforms that differ in their 3' untranslated region, only one of which is subject to miR-221-222 regulation. Additionally, transgenic expression of miR-221-222 from bacterial artificial chromosome clones in embryonic stem cells dramatically reduced cell proliferation and severely impaired their accumulation. Our study provides further insights on miR-221-222 transcriptional regulation as well as evidences that miR-221-222 regulate cell cycle checkpoints in mast cells in response to acute activation stimuli.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19109175      PMCID: PMC2610349          DOI: 10.4049/jimmunol.182.1.433

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  PipMaker--a web server for aligning two genomic DNA sequences.

Authors:  S Schwartz; Z Zhang; K A Frazer; A Smit; C Riemer; J Bouck; R Gibbs; R Hardison; W Miller
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

2.  T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes.

Authors:  Orly Avni; Dong Lee; Fernando Macian; Susanne J Szabo; Laurie H Glimcher; Anjana Rao
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

3.  Widespread changes in protein synthesis induced by microRNAs.

Authors:  Matthias Selbach; Björn Schwanhäusser; Nadine Thierfelder; Zhuo Fang; Raya Khanin; Nikolaus Rajewsky
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

4.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

5.  PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein.

Authors:  Catherine Labbaye; Maria Teresa Quaranta; Alfredo Pagliuca; Stefania Militi; Jonathan D Licht; Ugo Testa; Cesare Peschle
Journal:  Oncogene       Date:  2002-09-26       Impact factor: 9.867

6.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

7.  A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis.

Authors:  Catherine Labbaye; Isabella Spinello; Maria Teresa Quaranta; Elvira Pelosi; Luca Pasquini; Eleonora Petrucci; Mauro Biffoni; Eugenia Rosa Nuzzolo; Monia Billi; Robin Foà; Ercole Brunetti; Francesco Grignani; Ugo Testa; Cesare Peschle
Journal:  Nat Cell Biol       Date:  2008-06-22       Impact factor: 28.824

8.  The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

Authors:  Federica Felicetti; M Cristina Errico; Lisabianca Bottero; Patrizia Segnalini; Antonella Stoppacciaro; Mauro Biffoni; Nadia Felli; Gianfranco Mattia; Marina Petrini; Mario P Colombo; Cesare Peschle; Alessandra Carè
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

9.  A 3' enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells.

Authors:  Deborah C Solymar; Suneet Agarwal; Craig H Bassing; Frederick W Alt; Anjana Rao
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

10.  Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage.

Authors:  Alan B Cantor; Hiromi Iwasaki; Yojiro Arinobu; Tyler B Moran; Hirokazu Shigematsu; Matthew R Sullivan; Koichi Akashi; Stuart H Orkin
Journal:  J Exp Med       Date:  2008-02-25       Impact factor: 14.307

View more
  45 in total

1.  miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo.

Authors:  Deena M Leslie Pedrioli; Terhi Karpanen; Vasilios Dabouras; Giorgia Jurisic; Glenn van de Hoek; Jay W Shin; Daniela Marino; Roland E Kälin; Sebastian Leidel; Paolo Cinelli; Stefan Schulte-Merker; André W Brändli; Michael Detmar
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

2.  Inhibition of miRNA-221 suppresses the airway inflammation in asthma.

Authors:  Hou-bing Qin; Bing Xu; Juan-juan Mei; Dan Li; Juan-juan Liu; De-yu Zhao; Feng Liu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

3.  MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.

Authors:  Anna Aakula; Suvi-Katri Leivonen; Petteri Hintsanen; Tero Aittokallio; Yvonne Ceder; Anne-Lise Børresen-Dale; Merja Perälä; Päivi Östling; Olli Kallioniemi
Journal:  Mol Oncol       Date:  2015-03-21       Impact factor: 6.603

Review 4.  Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer.

Authors:  Carole A Oskeritzian
Journal:  Mol Immunol       Date:  2014-04-22       Impact factor: 4.407

Review 5.  MicroRNAs in allergy and asthma.

Authors:  Ana Rebane; Cezmi A Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2014-04       Impact factor: 4.806

Review 6.  MicroRNAs as regulatory elements in immune system logic.

Authors:  Arnav Mehta; David Baltimore
Journal:  Nat Rev Immunol       Date:  2016-04-28       Impact factor: 53.106

Review 7.  miR-221/222: promising biomarkers for breast cancer.

Authors:  Wei-Xian Chen; Qing Hu; Man-Tang Qiu; Shan-Liang Zhong; Jin-Jin Xu; Jin-Hai Tang; Jian-Hua Zhao
Journal:  Tumour Biol       Date:  2013-03-27

8.  MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.

Authors:  Julie Halkein; Sebastien P Tabruyn; Melanie Ricke-Hoch; Arash Haghikia; Ngoc-Quynh-Nhu Nguyen; Michaela Scherr; Karolien Castermans; Ludovic Malvaux; Vincent Lambert; Marc Thiry; Karen Sliwa; Agnes Noel; Joseph A Martial; Denise Hilfiker-Kleiner; Ingrid Struman
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

9.  Prioritization of disease microRNAs through a human phenome-microRNAome network.

Authors:  Qinghua Jiang; Yangyang Hao; Guohua Wang; Liran Juan; Tianjiao Zhang; Mingxiang Teng; Yunlong Liu; Yadong Wang
Journal:  BMC Syst Biol       Date:  2010-05-28

Review 10.  MicroRNA regulation of allergic inflammation and asthma.

Authors:  Heather H Pua; K Mark Ansel
Journal:  Curr Opin Immunol       Date:  2015-08-05       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.